RNA interference and cancer therapy: methods and protocols
This comprehensive volume collects a repertoire of techniques for the adoption and exploitation of RNA interference (RNAi) as a fertile strategy to develop the bio-drugs of future in the vital field of cancer research. Exploring the immense 'bench to bedside' potential of RNAi as a therape...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York, NY
Springer New York
2019
|
| Ausgabe: | 1st ed. 2019 |
| Schriftenreihe: | Methods in Molecular Biology
1974 |
| Schlagworte: | |
| Online-Zugang: | UBR01 TUM01 URL des Erstveröffentlichers |
| Zusammenfassung: | This comprehensive volume collects a repertoire of techniques for the adoption and exploitation of RNA interference (RNAi) as a fertile strategy to develop the bio-drugs of future in the vital field of cancer research. Exploring the immense 'bench to bedside' potential of RNAi as a therapeutic molecule, the book focuses many of its chapters on nanoparticle-based targeted deliveries, including aptamers, as well as techniques for using RNAi technology to combat various cancers in preclinical studies. Each of the 26 chapters is authored by the pioneers in the respective areas and thus provides a practical and empirical account of the techniques that could be used as benchmark tools in the area of cancer research. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and essential, RNA Interference and Cancer Therapy: Methods and Protocols provides the necessary guidance for both novice and professional researchers who intend to discover and innovate newer means of using RNAi technology to combat cancer, one of the greatest scourges of human health |
| Beschreibung: | siRNA Library Screening to Identify Complementary Therapeutic Pairs in Triple Negative Breast Cancer Cells -- In Vitro Evaluation of Candidate Gene Targets for Cancer Therapy -- siRNA-Based Drug Targeting Human Bcl-xL against Cancers -- Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly-Active siRNAs -- VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier -- Design Strategy to Access siRNA-Encapsulating DNA "Nanosuitcases" that Can Conditionally Release their Cargo -- Combinatorial siRNA Polyplexes for Receptor Targeting -- Synthesis of Doxorubicin and miRNA Stimuli-Sensitive Conjugates for Combination Therapy -- Minicell-Based Targeted Delivery of shRNA to Cancer Cells: An Experimental Protocol -- Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo -- Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid Nanoparticles -- - Targeting Cancer with Peptide RNAi Nanoplexes -- Preparation of a Carrier to Achieve In Vivo Delivery of siRNA: The Example of Chitosan-Coated Poly(isobutylcyanoacrylate) Nanoparticles -- Monoclonal Antibody-Conjugated Dendritic Nanostructures for siRNA Delivery -- Synthesis of Gold Nanoparticles for Gene Silencing -- Design of Eco-Friendly Gold Nanoparticles for Cancer Treatment -- 64Cu-Labeled Aptamers for Tumor-Targeted Radionuclide Delivery -- Silencing PRDM14 via Oligonucleotide Therapeutics Suppresses Tumorigenicity and Metastasis of Breast Cancer -- Bio-Drug Suppresses Breast and Colorectal Cancer in Murine Models -- Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment -- Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells -- Vaginal Suppositories with siRNA and Paclitaxel-Incorporated Solid Lipid Nanoparticles for Cervical Cancer: Preparation and In Vitro Evaluation -- - The Use of Star Polymer Nanoparticles for the Delivery of siRNA to Mouse Orthotopic Pancreatic Tumor Models -- Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of Ovarian Cancer -- Synthesis, Physico-Chemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma -- Folate-Decorated Polyamidoamine Dendrimer Nanoparticles for Head and Neck Cancer Gene Therapy |
| Beschreibung: | 1 Online-Ressource (XIII, 416 Seiten) Illustrationen |
| ISBN: | 9781493992201 |
| DOI: | 10.1007/978-1-4939-9220-1 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV047646858 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 211217s2019 |||| o||u| ||||||eng d | ||
| 020 | |a 9781493992201 |c Online |9 978-1-4939-9220-1 | ||
| 024 | 7 | |a 10.1007/978-1-4939-9220-1 |2 doi | |
| 035 | |a (ZDB-2-PRO)978-1-4939-9220-1 | ||
| 035 | |a (OCoLC)1289764787 | ||
| 035 | |a (DE-599)BVBBV047646858 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-91 | ||
| 082 | 0 | |a 614.5999 | |
| 084 | |a WD 5355 |0 (DE-625)148201: |2 rvk | ||
| 084 | |a KH 3200 |0 (DE-625)76426: |2 rvk | ||
| 245 | 1 | 0 | |a RNA interference and cancer therapy |b methods and protocols |c edited by Lekha Dinesh Kumar |
| 250 | |a 1st ed. 2019 | ||
| 264 | 1 | |a New York, NY |b Springer New York |c 2019 | |
| 300 | |a 1 Online-Ressource (XIII, 416 Seiten) |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Methods in Molecular Biology | |
| 490 | 0 | |a 1974 | |
| 500 | |a siRNA Library Screening to Identify Complementary Therapeutic Pairs in Triple Negative Breast Cancer Cells -- In Vitro Evaluation of Candidate Gene Targets for Cancer Therapy -- siRNA-Based Drug Targeting Human Bcl-xL against Cancers -- Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly-Active siRNAs -- VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier -- Design Strategy to Access siRNA-Encapsulating DNA "Nanosuitcases" that Can Conditionally Release their Cargo -- Combinatorial siRNA Polyplexes for Receptor Targeting -- Synthesis of Doxorubicin and miRNA Stimuli-Sensitive Conjugates for Combination Therapy -- Minicell-Based Targeted Delivery of shRNA to Cancer Cells: An Experimental Protocol -- Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo -- Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid Nanoparticles -- | ||
| 500 | |a - Targeting Cancer with Peptide RNAi Nanoplexes -- Preparation of a Carrier to Achieve In Vivo Delivery of siRNA: The Example of Chitosan-Coated Poly(isobutylcyanoacrylate) Nanoparticles -- Monoclonal Antibody-Conjugated Dendritic Nanostructures for siRNA Delivery -- Synthesis of Gold Nanoparticles for Gene Silencing -- Design of Eco-Friendly Gold Nanoparticles for Cancer Treatment -- 64Cu-Labeled Aptamers for Tumor-Targeted Radionuclide Delivery -- Silencing PRDM14 via Oligonucleotide Therapeutics Suppresses Tumorigenicity and Metastasis of Breast Cancer -- Bio-Drug Suppresses Breast and Colorectal Cancer in Murine Models -- Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment -- Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells -- Vaginal Suppositories with siRNA and Paclitaxel-Incorporated Solid Lipid Nanoparticles for Cervical Cancer: Preparation and In Vitro Evaluation -- | ||
| 500 | |a - The Use of Star Polymer Nanoparticles for the Delivery of siRNA to Mouse Orthotopic Pancreatic Tumor Models -- Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of Ovarian Cancer -- Synthesis, Physico-Chemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma -- Folate-Decorated Polyamidoamine Dendrimer Nanoparticles for Head and Neck Cancer Gene Therapy | ||
| 520 | |a This comprehensive volume collects a repertoire of techniques for the adoption and exploitation of RNA interference (RNAi) as a fertile strategy to develop the bio-drugs of future in the vital field of cancer research. Exploring the immense 'bench to bedside' potential of RNAi as a therapeutic molecule, the book focuses many of its chapters on nanoparticle-based targeted deliveries, including aptamers, as well as techniques for using RNAi technology to combat various cancers in preclinical studies. Each of the 26 chapters is authored by the pioneers in the respective areas and thus provides a practical and empirical account of the techniques that could be used as benchmark tools in the area of cancer research. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and essential, RNA Interference and Cancer Therapy: Methods and Protocols provides the necessary guidance for both novice and professional researchers who intend to discover and innovate newer means of using RNAi technology to combat cancer, one of the greatest scourges of human health | ||
| 650 | 4 | |a Cancer research | |
| 650 | 4 | |a Human genetics | |
| 650 | 4 | |a Pharmaceutical technology | |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a RNS-Interferenz |0 (DE-588)4802706-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a RNS-Interferenz |0 (DE-588)4802706-6 |D s |
| 689 | 0 | 1 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 2 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Kumar, Lekha Dinesh |0 (DE-588)1192391225 |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-4939-9222-5 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4939-9220-1 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-PRO | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-033030981 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-4939-9220-1 |l UBR01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-1-4939-9220-1 |l TUM01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804183108311842816 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Kumar, Lekha Dinesh |
| author2_role | edt |
| author2_variant | l d k ld ldk |
| author_GND | (DE-588)1192391225 |
| author_facet | Kumar, Lekha Dinesh |
| building | Verbundindex |
| bvnumber | BV047646858 |
| classification_rvk | WD 5355 KH 3200 |
| collection | ZDB-2-PRO |
| ctrlnum | (ZDB-2-PRO)978-1-4939-9220-1 (OCoLC)1289764787 (DE-599)BVBBV047646858 |
| dewey-full | 614.5999 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 614 - Forensic medicine; incidence of disease |
| dewey-raw | 614.5999 |
| dewey-search | 614.5999 |
| dewey-sort | 3614.5999 |
| dewey-tens | 610 - Medicine and health |
| discipline | Biologie Slavistik Medizin |
| discipline_str_mv | Biologie Slavistik Medizin |
| doi_str_mv | 10.1007/978-1-4939-9220-1 |
| edition | 1st ed. 2019 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05811nmm a2200589zc 4500</leader><controlfield tag="001">BV047646858</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">211217s2019 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781493992201</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-4939-9220-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4939-9220-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-4939-9220-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1289764787</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047646858</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">614.5999</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WD 5355</subfield><subfield code="0">(DE-625)148201:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">KH 3200</subfield><subfield code="0">(DE-625)76426:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">RNA interference and cancer therapy</subfield><subfield code="b">methods and protocols</subfield><subfield code="c">edited by Lekha Dinesh Kumar</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2019</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Springer New York</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIII, 416 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods in Molecular Biology</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">1974</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">siRNA Library Screening to Identify Complementary Therapeutic Pairs in Triple Negative Breast Cancer Cells -- In Vitro Evaluation of Candidate Gene Targets for Cancer Therapy -- siRNA-Based Drug Targeting Human Bcl-xL against Cancers -- Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly-Active siRNAs -- VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier -- Design Strategy to Access siRNA-Encapsulating DNA "Nanosuitcases" that Can Conditionally Release their Cargo -- Combinatorial siRNA Polyplexes for Receptor Targeting -- Synthesis of Doxorubicin and miRNA Stimuli-Sensitive Conjugates for Combination Therapy -- Minicell-Based Targeted Delivery of shRNA to Cancer Cells: An Experimental Protocol -- Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo -- Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid Nanoparticles -- </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - Targeting Cancer with Peptide RNAi Nanoplexes -- Preparation of a Carrier to Achieve In Vivo Delivery of siRNA: The Example of Chitosan-Coated Poly(isobutylcyanoacrylate) Nanoparticles -- Monoclonal Antibody-Conjugated Dendritic Nanostructures for siRNA Delivery -- Synthesis of Gold Nanoparticles for Gene Silencing -- Design of Eco-Friendly Gold Nanoparticles for Cancer Treatment -- 64Cu-Labeled Aptamers for Tumor-Targeted Radionuclide Delivery -- Silencing PRDM14 via Oligonucleotide Therapeutics Suppresses Tumorigenicity and Metastasis of Breast Cancer -- Bio-Drug Suppresses Breast and Colorectal Cancer in Murine Models -- Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment -- Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells -- Vaginal Suppositories with siRNA and Paclitaxel-Incorporated Solid Lipid Nanoparticles for Cervical Cancer: Preparation and In Vitro Evaluation -- </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - The Use of Star Polymer Nanoparticles for the Delivery of siRNA to Mouse Orthotopic Pancreatic Tumor Models -- Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of Ovarian Cancer -- Synthesis, Physico-Chemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma -- Folate-Decorated Polyamidoamine Dendrimer Nanoparticles for Head and Neck Cancer Gene Therapy</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This comprehensive volume collects a repertoire of techniques for the adoption and exploitation of RNA interference (RNAi) as a fertile strategy to develop the bio-drugs of future in the vital field of cancer research. Exploring the immense 'bench to bedside' potential of RNAi as a therapeutic molecule, the book focuses many of its chapters on nanoparticle-based targeted deliveries, including aptamers, as well as techniques for using RNAi technology to combat various cancers in preclinical studies. Each of the 26 chapters is authored by the pioneers in the respective areas and thus provides a practical and empirical account of the techniques that could be used as benchmark tools in the area of cancer research. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and essential, RNA Interference and Cancer Therapy: Methods and Protocols provides the necessary guidance for both novice and professional researchers who intend to discover and innovate newer means of using RNAi technology to combat cancer, one of the greatest scourges of human health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical technology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">RNS-Interferenz</subfield><subfield code="0">(DE-588)4802706-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">RNS-Interferenz</subfield><subfield code="0">(DE-588)4802706-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kumar, Lekha Dinesh</subfield><subfield code="0">(DE-588)1192391225</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-4939-9222-5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4939-9220-1</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033030981</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4939-9220-1</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4939-9220-1</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV047646858 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T18:48:57Z |
| indexdate | 2024-07-10T09:18:12Z |
| institution | BVB |
| isbn | 9781493992201 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033030981 |
| oclc_num | 1289764787 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
| owner_facet | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource (XIII, 416 Seiten) Illustrationen |
| psigel | ZDB-2-PRO |
| publishDate | 2019 |
| publishDateSearch | 2019 |
| publishDateSort | 2019 |
| publisher | Springer New York |
| record_format | marc |
| series2 | Methods in Molecular Biology 1974 |
| spelling | RNA interference and cancer therapy methods and protocols edited by Lekha Dinesh Kumar 1st ed. 2019 New York, NY Springer New York 2019 1 Online-Ressource (XIII, 416 Seiten) Illustrationen txt rdacontent c rdamedia cr rdacarrier Methods in Molecular Biology 1974 siRNA Library Screening to Identify Complementary Therapeutic Pairs in Triple Negative Breast Cancer Cells -- In Vitro Evaluation of Candidate Gene Targets for Cancer Therapy -- siRNA-Based Drug Targeting Human Bcl-xL against Cancers -- Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly-Active siRNAs -- VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier -- Design Strategy to Access siRNA-Encapsulating DNA "Nanosuitcases" that Can Conditionally Release their Cargo -- Combinatorial siRNA Polyplexes for Receptor Targeting -- Synthesis of Doxorubicin and miRNA Stimuli-Sensitive Conjugates for Combination Therapy -- Minicell-Based Targeted Delivery of shRNA to Cancer Cells: An Experimental Protocol -- Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo -- Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid Nanoparticles -- - Targeting Cancer with Peptide RNAi Nanoplexes -- Preparation of a Carrier to Achieve In Vivo Delivery of siRNA: The Example of Chitosan-Coated Poly(isobutylcyanoacrylate) Nanoparticles -- Monoclonal Antibody-Conjugated Dendritic Nanostructures for siRNA Delivery -- Synthesis of Gold Nanoparticles for Gene Silencing -- Design of Eco-Friendly Gold Nanoparticles for Cancer Treatment -- 64Cu-Labeled Aptamers for Tumor-Targeted Radionuclide Delivery -- Silencing PRDM14 via Oligonucleotide Therapeutics Suppresses Tumorigenicity and Metastasis of Breast Cancer -- Bio-Drug Suppresses Breast and Colorectal Cancer in Murine Models -- Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment -- Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells -- Vaginal Suppositories with siRNA and Paclitaxel-Incorporated Solid Lipid Nanoparticles for Cervical Cancer: Preparation and In Vitro Evaluation -- - The Use of Star Polymer Nanoparticles for the Delivery of siRNA to Mouse Orthotopic Pancreatic Tumor Models -- Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of Ovarian Cancer -- Synthesis, Physico-Chemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma -- Folate-Decorated Polyamidoamine Dendrimer Nanoparticles for Head and Neck Cancer Gene Therapy This comprehensive volume collects a repertoire of techniques for the adoption and exploitation of RNA interference (RNAi) as a fertile strategy to develop the bio-drugs of future in the vital field of cancer research. Exploring the immense 'bench to bedside' potential of RNAi as a therapeutic molecule, the book focuses many of its chapters on nanoparticle-based targeted deliveries, including aptamers, as well as techniques for using RNAi technology to combat various cancers in preclinical studies. Each of the 26 chapters is authored by the pioneers in the respective areas and thus provides a practical and empirical account of the techniques that could be used as benchmark tools in the area of cancer research. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and essential, RNA Interference and Cancer Therapy: Methods and Protocols provides the necessary guidance for both novice and professional researchers who intend to discover and innovate newer means of using RNAi technology to combat cancer, one of the greatest scourges of human health Cancer research Human genetics Pharmaceutical technology Therapie (DE-588)4059798-2 gnd rswk-swf RNS-Interferenz (DE-588)4802706-6 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content RNS-Interferenz (DE-588)4802706-6 s Krebs Medizin (DE-588)4073781-0 s Therapie (DE-588)4059798-2 s DE-604 Kumar, Lekha Dinesh (DE-588)1192391225 edt Erscheint auch als Druck-Ausgabe 978-1-4939-9222-5 https://doi.org/10.1007/978-1-4939-9220-1 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | RNA interference and cancer therapy methods and protocols Cancer research Human genetics Pharmaceutical technology Therapie (DE-588)4059798-2 gnd RNS-Interferenz (DE-588)4802706-6 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4059798-2 (DE-588)4802706-6 (DE-588)4073781-0 (DE-588)4143413-4 |
| title | RNA interference and cancer therapy methods and protocols |
| title_auth | RNA interference and cancer therapy methods and protocols |
| title_exact_search | RNA interference and cancer therapy methods and protocols |
| title_exact_search_txtP | RNA interference and cancer therapy methods and protocols |
| title_full | RNA interference and cancer therapy methods and protocols edited by Lekha Dinesh Kumar |
| title_fullStr | RNA interference and cancer therapy methods and protocols edited by Lekha Dinesh Kumar |
| title_full_unstemmed | RNA interference and cancer therapy methods and protocols edited by Lekha Dinesh Kumar |
| title_short | RNA interference and cancer therapy |
| title_sort | rna interference and cancer therapy methods and protocols |
| title_sub | methods and protocols |
| topic | Cancer research Human genetics Pharmaceutical technology Therapie (DE-588)4059798-2 gnd RNS-Interferenz (DE-588)4802706-6 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Cancer research Human genetics Pharmaceutical technology Therapie RNS-Interferenz Krebs Medizin Aufsatzsammlung |
| url | https://doi.org/10.1007/978-1-4939-9220-1 |
| work_keys_str_mv | AT kumarlekhadinesh rnainterferenceandcancertherapymethodsandprotocols |